Foto del docente

Serena Montanari

Junior assistant professor (fixed-term)

Department for Life Quality Studies

Academic discipline: CHIM/08 Pharmaceutical Chemistry

Publications

Serena Montanari, Angela De Simone, Lara Davani, Cristina Terenzi, Vincenzo Tumiatti, Vincenza Andrisano, Analytical characterization of commercial microalgae, in: AbstractBook_Comunicazione orale, 2021, pp. 70 - 70 (atti di: 31 International Symposium on Pharmaceutical and Biomedical Analysis, Kyoto, Japan, online, 29/08/2021-01/09/2021) [Contribution to conference proceedings]

Lara Davani, Xiaoqing Fu, Angela De Simone, Peng Li, Serena Montanari, Michael Lämmerhofer, Vincenza Andrisano, Aß42 peptide toxicity on neuronal cells: a lipidomic study in view of Alzheimer’s Disease drug discovery, in: Atto di convegno, 2021(atti di: RDPA, Modena, online, 6-8/09/2021) [Poster]

Angela De Simone, Serena Montanari, Lara Davani, Eliska Emrichova, Vincenza Andrisano, Clara Grosso, Characterization of herbal medicine as novel GSK-3β inhibitors endowed with multi-targets neuroprotective effects, in: Atto di convegno, 2021(atti di: 2nd International Conference on Neuroprotection by Drugs, Nutraceuticals, and Physical Activity, online, 9-10/12/2021) [Poster]

De Simone A.; Davani L.; Montanari S.; Tumiatti V.; Avanessian S.; Testi F.; Andrisano V., Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations, «FRONTIERS IN CHEMISTRY», 2021, 9, Article number: 741876 , pp. 1 - 13 [Scientific article]Open Access

Serena Montanari, Angela De Simone, Lara Davani, Marianna Ricci, Vincenza Andrisano, Development and Validation of a Gas Chromatographic–Mass Spectrometric (GC–MS) Method for the Determination of Fentanyl in Blood of Cancer Patients, in: AbstractBook_Comunicazione orale, 2021, pp. 38 - 39 (atti di: Recent Developments in Pharmaceutical Analysis, Modena, online, 6-8/09/2021) [Contribution to conference proceedings]

Lara Davani, Xiaoqing Fu, Angela De Simone, Peng Li, Serena Montanari, Michael Lämmerhofer, Vincenza Andrisano, Development of Advanced Analytical Methodologies for Alzheimer’s Disease Drug Discovery, in: SSPA2021_AbstractBook_Comunicazione orale, 2021, pp. 348 - 351 (atti di: SSPA, online, 22–24/09/2021) [Contribution to conference proceedings]

Montanari S.; Davani L.; Tumiatti V.; Dimilta M.; Gaddi A.V.; De Simone A.; Andrisano V., Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma, «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2021, 198, Article number: 113985 , pp. 1 - 7 [Scientific article]Open Access

Serena Montanari, Angela De Simone, Lara Davani, Marianna Ricci, Vincenza Andrisano, Fentanyl pharmacokinetic study for genetic polymorphisms correlation in cancer patients, in: Atto di convegno, 2021(atti di: XXVII Congresso Nazionale della Società Chimica Italiana, online, 14-23/09/2021) [Poster]

Lara Davani, Xiaoqing Fu, Angela De Simone, Peng Li, Serena Montanari, Michael Lämmerhofer, Vincenza Andrisano, Investigation of Aß peptide effects on SH-SY5Y cells: a lipidomic approach for Alzheimer’s Disease drug discovery, in: AbstractBook_Comunicazione orale, 2021, pp. 52 - 52 (atti di: NPCF13, online, 26-29/04/2021) [Contribution to conference proceedings]

Montanari S.; Allara M.; Scalvini L.; Kostrzewa M.; Belluti F.; Gobbi S.; Naldi M.; Rivara S.; Bartolini M.; Ligresti A.; Bisi A.; Rampa A., New Coumarin derivatives as cholinergic and cannabinoid system modulators, «MOLECULES», 2021, 26, Article number: 3254 , pp. 1 - 18 [Scientific article]Open Access

Catanzaro E.; Betari N.; Arencibia J.M.; Montanari S.; Sissi C.; De Simone A.; Vassura I.; Santini A.; Andrisano V.; Tumiatti V.; De Vivo M.; Krysko D.V.; Rocchi M.B.L.; Fimognari C.; Milelli A., Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2020, 202, Article number: 112504 , pp. 112504 - 112504 [Scientific article]Open Access

De Simone A.; La Pietra V.; Betari N.; Petragnani N.; Conte M.; Daniele S.; Pietrobono D.; Martini C.; Petralla S.; Casadei R.; Davani L.; Frabetti F.; Russomanno P.; Novellino E.; Montanari S.; Tumiatti V.; Ballerini P.; Sarno F.; Nebbioso A.; Altucci L.; Monti B.; Andrisano V.; Milelli A., Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507), «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 1357 - 1357 [Scientific article]

Montanari S.; Mahmoud A.M.; Pruccoli L.; Rabbito A.; Naldi M.; Petralla S.; Moraleda I.; Bartolini M.; Monti B.; Iriepa I.; Belluti F.; Gobbi S.; Di Marzo V.; Bisi A.; Tarozzi A.; Ligresti A.; Rampa A., Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2019, 178, pp. 243 - 258 [Scientific article]Open Access

De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Petralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A., Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease., «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 469 - 474 [Scientific article]Open Access

Latest news

At the moment no news are available.